RecruitingNot Applicable

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

United States100 participantsStarted 2025-05-16

Plain-language summary

This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.

Who can participate

Age range

18 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-50 * English or Spanish speaking * A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age) * Singleton or multiple gestation pregnancy, * A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts * Willing to share home blood pressure monitoring data * Comfortable with the use of smartphones and mobile apps Exclusion Criteria: * Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg) * Current diagnosis of preeclampsia * Active substance use * Serious physical illness (e.g., unable to interact with a smart device) * Enrolled in another home blood pressure monitoring program * Excluded from study participation by their provider * Inability to provide informed consent * Prisoners/institutionalized individuals

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Home Blood Pressure Monitoring Adherence

Timeframe: 8 weeks

Feasibility of the Moms@Home intervention

Timeframe: 8 weeks

Acceptability

Timeframe: 8 weeks

Trial details

NCT IDNCT06835959

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-07-16

Contact for this trial

Lara Kovell, MD,MSc

(508) 856-2772 lara.kovell2@umassmed.edu

View on ClinicalTrials.gov More Hypertension in Pregnancy trials

Who can participate

Age range

18 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.